|Bid||1.4000 x 1200|
|Ask||1.4500 x 3000|
|Day's Range||1.4000 - 1.4900|
|52 Week Range||1.0200 - 3.6500|
|Beta (5Y Monthly)||1.09|
|PE Ratio (TTM)||10.36|
|Earnings Date||Jun 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Is China Natural Resources, Inc. (NASDAQ:CHNR) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise […]
CHINA NATURAL RESOURCES, INC. (NASDAQ: CHNR) (the "Company") today announced its results of operations for the year ended December 31, 2020. For the convenience of the reader, amounts in Chinese Yuan ("CNY") have been translated into United States dollars ("US$") at the rate of US$1.00 = CNY6.5306 as quoted by www.ofx.com on December 31, 2020.
China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") announced today the appointment of pharmaceutical industry executive Peng Wenlie as Vice President, effective March 22, 2021. Dr. Peng, who brings more than 20 years of experience working in the industry, will report directly to the Company's Chairman, Mr. Wong Wah On Edward. He will be responsible for evaluating the Company's investment opportunities in the healthcare, biomedicine, and related markets.